An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival
- Resource Type
- Article
- Source
- In
Annals of Oncology December 2011 22(12):2625-2630 - Subject
- Language
- ISSN
- 0923-7534